
### [MONDO:0000447](http://purl.obolibrary.org/obo/MONDO_0000447)
**Label:** polycystic liver disease (disease)

**Subclasses:** [MONDO:0014860](http://purl.obolibrary.org/obo/MONDO_0014860) (polycystic liver disease 2; PCLD2), [MONDO:0008265](http://purl.obolibrary.org/obo/MONDO_0008265) (isolated polycystic liver disease), 

**Mapped go classes:** [GO:0015031](http://purl.obolibrary.org/obo/GO_0015031) (protein transport), [GO:0008565](http://purl.obolibrary.org/obo/GO_0008565) (protein transporter activity), [GO:0042552](http://purl.obolibrary.org/obo/GO_0042552) (myelination), [GO:0051291](http://purl.obolibrary.org/obo/GO_0051291) (protein heterooligomerization), [GO:0006620](http://purl.obolibrary.org/obo/GO_0006620) (posttranslational protein targeting to endoplasmic reticulum membrane), [GO:0005789](http://purl.obolibrary.org/obo/GO_0005789) (endoplasmic reticulum membrane), [GO:0003723](http://purl.obolibrary.org/obo/GO_0003723) (RNA binding), [GO:0006614](http://purl.obolibrary.org/obo/GO_0006614) (SRP-dependent cotranslational protein targeting to membrane), [GO:0004558](http://purl.obolibrary.org/obo/GO_0004558) (alpha-1,4-glucosidase activity), [GO:0030968](http://purl.obolibrary.org/obo/GO_0030968) (endoplasmic reticulum unfolded protein response), [GO:0010977](http://purl.obolibrary.org/obo/GO_0010977) (negative regulation of neuron projection development), [GO:0001701](http://purl.obolibrary.org/obo/GO_0001701) (in utero embryonic development), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0072001](http://purl.obolibrary.org/obo/GO_0072001) (renal system development), [GO:0010259](http://purl.obolibrary.org/obo/GO_0010259) (multicellular organism aging), [GO:0016310](http://purl.obolibrary.org/obo/GO_0016310) (phosphorylation), [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding), [GO:0006491](http://purl.obolibrary.org/obo/GO_0006491) (N-glycan processing), [GO:0005783](http://purl.obolibrary.org/obo/GO_0005783) (endoplasmic reticulum), [GO:0046967](http://purl.obolibrary.org/obo/GO_0046967) (cytosol to ER transport), [GO:0006810](http://purl.obolibrary.org/obo/GO_0006810) (transport), [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding), [GO:0048793](http://purl.obolibrary.org/obo/GO_0048793) (pronephros development), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane), [GO:0031965](http://purl.obolibrary.org/obo/GO_0031965) (nuclear membrane), [GO:0031207](http://purl.obolibrary.org/obo/GO_0031207) (Sec62/Sec63 complex), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0006807](http://purl.obolibrary.org/obo/GO_0006807) (nitrogen compound metabolic process), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0017177](http://purl.obolibrary.org/obo/GO_0017177) (glucosidase II complex), [GO:0051219](http://purl.obolibrary.org/obo/GO_0051219) (phosphoprotein binding), [GO:0031204](http://purl.obolibrary.org/obo/GO_0031204) (posttranslational protein targeting to membrane, translocation), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0016301](http://purl.obolibrary.org/obo/GO_0016301) (kinase activity), 

**Class expressions from DL-Learner:**

- [GO:0045047](http://purl.obolibrary.org/obo/GO_0045047) (protein targeting to ER) 58.33%
- [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane) and [GO:0072599](http://purl.obolibrary.org/obo/GO_0072599) (establishment of protein localization to endoplasmic reticulum) 58.33%
- [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane) and [GO:0070972](http://purl.obolibrary.org/obo/GO_0070972) (protein localization to endoplasmic reticulum) 58.33%
- [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane) and [GO:0045047](http://purl.obolibrary.org/obo/GO_0045047) (protein targeting to ER) 58.33%
- [GO:0006612](http://purl.obolibrary.org/obo/GO_0006612) (protein targeting to membrane) and [GO:0070972](http://purl.obolibrary.org/obo/GO_0070972) (protein localization to endoplasmic reticulum) and [GO:0072594](http://purl.obolibrary.org/obo/GO_0072594) (establishment of protein localization to organelle) 58.33%
- [GO:0046967](http://purl.obolibrary.org/obo/GO_0046967) (cytosol to ER transport) 54.17%
- [GO:0044325](http://purl.obolibrary.org/obo/GO_0044325) (ion channel binding) 54.17%
- [GO:0031207](http://purl.obolibrary.org/obo/GO_0031207) (Sec62/Sec63 complex) 54.17%
- [GO:0017177](http://purl.obolibrary.org/obo/GO_0017177) (glucosidase II complex) 54.17%
- [GO:0006620](http://purl.obolibrary.org/obo/GO_0006620) (posttranslational protein targeting to endoplasmic reticulum membrane) 54.17%
- [GO:0006614](http://purl.obolibrary.org/obo/GO_0006614) (SRP-dependent cotranslational protein targeting to membrane) 54.17%
- [GO:0006613](http://purl.obolibrary.org/obo/GO_0006613) (cotranslational protein targeting to membrane) 54.17%
- [GO:0005637](http://purl.obolibrary.org/obo/GO_0005637) (nuclear inner membrane) 54.17%
- [GO:0005080](http://purl.obolibrary.org/obo/GO_0005080) (protein kinase C binding) 54.17%
- [GO:0019866](http://purl.obolibrary.org/obo/GO_0019866) (organelle inner membrane) and [GO:0044428](http://purl.obolibrary.org/obo/GO_0044428) (nuclear part) 54.17%


